Literature DB >> 21605605

Apoptosis and necrosis in vaccinia virus-infected HeLa G and BSC-40 cells.

Jana Liskova1, Jarmila Knitlova, Richard Honner, Zora Melkova.   

Abstract

In most cells, vaccinia virus (VACV) infection is considered to cause a lytic cell death, an equivalent of necrosis. However, upon infection of the epithelial cell lines HeLa G and BSC-40 with VACV strain Western Reserve (WR), we have previously observed an increased activation of and activity attributable to caspases, a typical sign of apoptosis. In this paper, we have further analyzed the type of cell death in VACV-infected cells HeLa G and BSC-40. In a cell-based flow cytometric assay, we showed a specific activation of caspase-2 and 4 in HeLa G and BSC-40 cells infected with VACV, strain WR, while we did not find any effects of inhibitors of calpain and cathepsin D and E. The actual activity of the two caspases, but also of caspase-3, was then confirmed in lysates of infected HeLa G, but not in BSC-40 cells. Accordingly, poly(ADP)-ribose polymerase (PARP) cleavage was found increased only in infected HeLa G cells. Consequently, we have determined morphological features of apoptosis and/or activity of the executioner caspase-3 in infected HeLa G cells in situ, while only a background apoptosis was observed in infected BSC-40 cells. Finally, vaccination strains Dryvax and Praha were found to induce apoptosis in both HeLa G and BSC-40 cells, as characterized morphologically and by PARP cleavage. These findings may be important for understanding the differences in VACV-host interactions and post-vaccination complications in different individuals.
Copyright © 2011 Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21605605     DOI: 10.1016/j.virusres.2011.05.005

Source DB:  PubMed          Journal:  Virus Res        ISSN: 0168-1702            Impact factor:   3.303


  9 in total

1.  Antitumor activity and immunogenicity of recombinant vaccinia virus expressing HPV 16 E7 protein SigE7LAMP is enhanced by high-level coexpression of IGFBP-3.

Authors:  J Musil; L Kutinova; K Zurkova; P Hainz; K Babiarova; J Krystofova; S Nemeckova
Journal:  Cancer Gene Ther       Date:  2014-02-21       Impact factor: 5.987

2.  Microglia and astrocytes attenuate the replication of the oncolytic vaccinia virus LIVP 1.1.1 in murine GL261 gliomas by acting as vaccinia virus traps.

Authors:  Christina Kober; Susanne Rohn; Stephanie Weibel; Ulrike Geissinger; Nanhai G Chen; Aladar A Szalay
Journal:  J Transl Med       Date:  2015-07-07       Impact factor: 5.531

3.  Apoptin enhances the oncolytic properties of vaccinia virus and modifies mechanisms of tumor regression.

Authors:  Galina Kochneva; Evgeniy Zonov; Antonina Grazhdantseva; Anastasiya Yunusova; Galina Sibolobova; Evgeniy Popov; Oleg Taranov; Sergei Netesov; Peter Chumakov; Elena Ryabchikova
Journal:  Oncotarget       Date:  2014-11-30

4.  Recombinant Vaccinia Viruses Coding Transgenes of Apoptosis-Inducing Proteins Enhance Apoptosis But Not Immunogenicity of Infected Tumor Cells.

Authors:  Olga Koval; Galina Kochneva; Anastasiya Tkachenko; Olga Troitskaya; Galina Sivolobova; Antonina Grazhdantseva; Anna Nushtaeva; Elena Kuligina; Vladimir Richter
Journal:  Biomed Res Int       Date:  2017-08-30       Impact factor: 3.411

5.  Oncolytic vaccinia virus combined with radiotherapy induces apoptotic cell death in sarcoma cells by down-regulating the inhibitors of apoptosis.

Authors:  Michelle J Wilkinson; Henry G Smith; Gráinne McEntee; Joan Kyula-Currie; Tim D Pencavel; David C Mansfield; Aadil A Khan; Victoria Roulstone; Andrew J Hayes; Kevin J Harrington
Journal:  Oncotarget       Date:  2016-12-06

6.  Induction of cell death in ovarian cancer cells by doxorubicin and oncolytic vaccinia virus is associated with CREB3L1 activation.

Authors:  Anna Mistarz; Matthew Graczyk; Marta Winkler; Prashant K Singh; Eduardo Cortes; Anthony Miliotto; Song Liu; Mark Long; Li Yan; Aimee Stablewski; Kieran O'Loughlin; Hans Minderman; Kunle Odunsi; Hanna Rokita; A J Robert McGray; Emese Zsiros; Danuta Kozbor
Journal:  Mol Ther Oncolytics       Date:  2021-04-29       Impact factor: 6.311

7.  Vaccinia virus induces programmed necrosis in ovarian cancer cells.

Authors:  Lynsey M Whilding; Kyra M Archibald; Hagen Kulbe; Frances R Balkwill; Daniel Öberg; Iain A McNeish
Journal:  Mol Ther       Date:  2013-09-24       Impact factor: 11.454

8.  Development of eczema vaccinatum in atopic mouse models and efficacy of MVA vaccination against lethal poxviral infection.

Authors:  Jarmila Knitlova; Vera Hajkova; Ludek Voska; Jana Elsterova; Barbora Obrova; Zora Melkova
Journal:  PLoS One       Date:  2014-12-08       Impact factor: 3.240

9.  Vaccinia Virus Expressing Interferon Regulatory Factor 3 Induces Higher Protective Immune Responses against Lethal Poxvirus Challenge in Atopic Organism.

Authors:  Hana Pilna; Vera Hajkova; Jarmila Knitlova; Jana Liskova; Jana Elsterova; Zora Melkova
Journal:  Viruses       Date:  2021-10-03       Impact factor: 5.048

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.